Bay Street News, November, 2018

WATERTOWN, Mass., Nov. 27, 2018 (GLOBE NEWSWIRE) — Aileron Therapeutics (NASDAQ: ALRN), the clinical-stage leader in the field of stabilized, […]

Santa Monica, CA, Nov. 27, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical […]

BOSTON, Nov. 27, 2018 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development […]

Appointment Furthers El Pollo Loco’s Commitment to Strengthening its Leadership Team COSTA MESA, Calif., Nov. 27, 2018 (GLOBE NEWSWIRE) — […]

New Location is in Columbia Mall in Columbia, Missouri LAS VEGAS, Nov. 27, 2018 (GLOBE NEWSWIRE) — Live Ventures Incorporated […]

BASKING RIDGE, N.J., Nov. 27, 2018 (GLOBE NEWSWIRE) — electroCore, Inc. (“electroCore”) (Nasdaq:ECOR), a commercial-stage bioelectronic medicine company, today announced expansion […]

Sildenafil Cream, 3.6% has the Potential to Receive the First FDA Approval for Female Sexual Arousal Disorder SAN DIEGO, Nov. […]

MALVERN, Pa. and SAN DIEGO, Calif., Nov. 27, 2018 (GLOBE NEWSWIRE) — PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical […]

EMERYVILLE, Calif., Nov. 27, 2018 (GLOBE NEWSWIRE) — Zogenix, Inc. (NASDAQ: ZGNX), a pharmaceutical company developing therapies for the treatment […]

SYDNEY, Australia, Nov. 27, 2018 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep“ or “the Company“), announces new […]